BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20068164)

  • 1. The high mobility group A1 gene: transforming inflammatory signals into cancer?
    Resar LM
    Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
    Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
    BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
    Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
    Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group A1 and cancer: potential biomarker and therapeutic target.
    Shah SN; Resar LM
    Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
    Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
    Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
    Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
    Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.
    Di Cello F; Dhara S; Hristov AC; Kowalski J; Elbahloul O; Hillion J; Roy S; Meijerink JP; Winter SS; Larson RS; Huso DL; Resar L
    Leuk Lymphoma; 2013 Aug; 54(8):1762-8. PubMed ID: 23311322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
    Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
    Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1 in cancer: Cancer classification by location.
    Wang Y; Hu L; Zheng Y; Guo L
    J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
    Wang L; Zhang J; Xia M; Liu C; Zu X; Zhong J
    Int J Biol Sci; 2022; 18(11):4414-4431. PubMed ID: 35864955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
    Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
    Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
    Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
    Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
    Li Y; Lu J; Prochownik EV
    J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.
    Esposito F; Tornincasa M; Chieffi P; De Martino I; Pierantoni GM; Fusco A
    Cancer Res; 2010 Jul; 70(13):5379-88. PubMed ID: 20530667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
    Chia L; Wang B; Kim JH; Luo LZ; Shuai S; Herrera I; Chen SY; Li L; Xian L; Huso T; Heydarian M; Reddy K; Sung WJ; Ishiyama S; Guo G; Jaffee E; Zheng L; Cope LM; Gabrielson K; Wood L; Resar L
    J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36919699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
    Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
    Huso TH; Resar LM
    Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.